/
PPCB
$1.52-$0.06 (-3.80%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.3M
2M shares
52-week range
$1.30 – $270.25
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
452.60%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-65999998.48
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $2.2K | $2.3K | $2.5K | $0 | $0 | $17.8K | $21.7K | $0 |
| Gross profit | −$2.2K | −$2.3K | −$2.5K | $0 | −$5.7K | −$17.8K | −$21.7K | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $1.8M | $260.3K | $180.0K | $231.0K | $256.1K | $247.9K | $248.1K | $223.7K |
| Operating income | −$4.0M | −$2.6M | −$3.5M | −$1.8M | −$2.0M | −$1.8M | −$1.5M | −$57.3M |
| EBITDA | −$4.4M | −$4.6M | −$3.1M | −$1.7M | −$2.1M | −$2.2M | −$1.3M | −$58.3M |
| Net income | −$7.0M | −$5.8M | −$4.7M | −$2.0M | −$2.7M | −$2.7M | −$1.8M | −$58.9M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -4468737303.25 | -274239389.25 | -4811228.75 | -20000.00 | -27986891.75 | -781709.75 | -30000.00 | -371.25 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Propanc Biopharma, Inc. Common Stock
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
www.propanc.com- Employees
- 2
- IPO / List date
- Jun 15, 2012
- HQ
- CAMBERWELL, VICTORIA, C3
Held by traders on TradeandTell
No one on the platform currently holds PPCB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PPCB as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-05-18 | 1-for-25reverse |
| 2025-01-29 | 1-for-60000reverse |
| 2023-05-23 | 1-for-1000reverse |
| 2020-11-19 | 1-for-1000reverse |
| 2019-06-24 | 1-for-500reverse |
Recent trades on TradeandTell
No one on the platform has traded PPCB yet.
